Phibro’s (PAHC) Big Acquisition Bet Just Cleared Its First Full Year

finance.yahoo.com · 2026-09-01

Phibro Animal Health (NASDAQ:PAHC) closed out fiscal 2026 with numbers that speak for themselves. Full-year net sales topped $1.5 billion, adjusted EBITDA climbed 39% to $255 million, and adjusted diluted earnings per share jumped 48% to $3.22. The results, covering the quarter and year ended June 30, mark the first complete fiscal year since the […]

Read the full story at finance.yahoo.com →